Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Wearable Devices for Precision Medicine and Health State Monitoring.

Jeong IC, Bychkov D, Searson PC.

IEEE Trans Biomed Eng. 2019 May;66(5):1242-1258. doi: 10.1109/TBME.2018.2871638.

PMID:
31021744
2.

Social media as a tool to monitor adherence to HIV antiretroviral therapy.

Bychkov D, Young S.

J Clin Transl Res. 2018 Mar 20;3(Suppl 3):407-410. eCollection 2018 Dec 17. No abstract available.

3.

Deep learning based tissue analysis predicts outcome in colorectal cancer.

Bychkov D, Linder N, Turkki R, Nordling S, Kovanen PE, Verrill C, Walliander M, Lundin M, Haglund C, Lundin J.

Sci Rep. 2018 Feb 21;8(1):3395. doi: 10.1038/s41598-018-21758-3.

4.

Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis.

Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki-Teeri P, Hemmes A, Välimäki K, Lundin J, Kallioniemi O, Pellinen T.

Sci Rep. 2017 Nov 14;7(1):15580. doi: 10.1038/s41598-017-15798-4.

5.

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.

Karjalainen R, Pemovska T, Popa M, Liu M, Javarappa KK, Majumder MM, Yadav B, Tamborero D, Tang J, Bychkov D, Kontro M, Parsons A, Suvela M, Mayoral Safont M, Porkka K, Aittokallio T, Kallioniemi O, McCormack E, Gjertsen BT, Wennerberg K, Knowles J, Heckman CA.

Blood. 2017 Aug 10;130(6):789-802. doi: 10.1182/blood-2016-02-699363. Epub 2017 Jun 15.

6.

Using a Real-Time Location System for Assessment of Patient Ambulation in a Hospital Setting.

Jeong IC, Bychkov D, Hiser S, Kreif JD, Klein LM, Hoyer EH, Searson PC.

Arch Phys Med Rehabil. 2017 Jul;98(7):1366-1373.e1. doi: 10.1016/j.apmr.2017.02.006. Epub 2017 Mar 9.

PMID:
28286202
7.

Social Media as a Tool to Reduce Sexual Misconduct in Medical Facilities.

Bychkov D, Young S.

Am J Med Qual. 2017 Jul/Aug;32(4):456-457. doi: 10.1177/1062860616688080. Epub 2017 Jan 30. No abstract available.

PMID:
28134559
8.

VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells.

Shein SA, Kuznetsov II, Abakumova TO, Chelushkin PS, Melnikov PA, Korchagina AA, Bychkov DA, Seregina IF, Bolshov MA, Kabanov AV, Chekhonin VP, Nukolova NV.

Mol Pharm. 2016 Nov 7;13(11):3712-3723. Epub 2016 Oct 3.

PMID:
27654150
9.

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer.

Saeed K, Rahkama V, Eldfors S, Bychkov D, Mpindi JP, Yadav B, Paavolainen L, Aittokallio T, Heckman C, Wennerberg K, Peehl DM, Horvath P, Mirtti T, Rannikko A, Kallioniemi O, Östling P, Af Hällström TM.

Eur Urol. 2017 Mar;71(3):319-327. doi: 10.1016/j.eururo.2016.04.019. Epub 2016 May 6.

10.

Serum Biomarkers of Allergic Contact Dermatitis: A Pilot Study.

Zinkevičienė A, Kainov D, Lastauskienė E, Kvedarienė V, Bychkov D, Byrne M, Girkontaitė I.

Int Arch Allergy Immunol. 2015;168(3):161-4. doi: 10.1159/000442749. Epub 2016 Jan 21.

11.

Genome-Wide Analysis of Evolutionary Markers of Human Influenza A(H1N1)pdm09 and A(H3N2) Viruses May Guide Selection of Vaccine Strain Candidates.

Belanov SS, Bychkov D, Benner C, Ripatti S, Ojala T, Kankainen M, Kai Lee H, Wei-Tze Tang J, Kainov DE.

Genome Biol Evol. 2015 Nov 27;7(12):3472-83. doi: 10.1093/gbe/evv240.

12.

Connexin 43-targeted T1 contrast agent for MRI diagnosis of glioma.

Abakumova T, Abakumov M, Shein S, Chelushkin P, Bychkov D, Mukhin V, Yusubalieva G, Grinenko N, Kabanov A, Nukolova N, Chekhonin V.

Contrast Media Mol Imaging. 2016 Jan-Feb;11(1):15-23. doi: 10.1002/cmmi.1653. Epub 2015 Aug 11.

PMID:
26265140
13.

Comparative Analysis of Whole-Genome Sequences of Influenza A(H1N1)pdm09 Viruses Isolated from Hospitalized and Nonhospitalized Patients Identifies Missense Mutations That Might Be Associated with Patient Hospital Admissions in Finland during 2009 to 2014.

Mishel P, Ojala T, Benner C, Lakspere T, Bychkov D, Jalovaara P, Kakkola L, Kallio-Kokko H, Kantele A, Kankainen M, Ikonen N, Ripatti S, Julkunen I, Kainov DE.

Genome Announc. 2015 Jul 30;3(4). pii: e00676-15. doi: 10.1128/genomeA.00676-15.

14.

Influenza pH1N1 Virus Accumulated H275Y Mutation in Neuraminidase during Propagation in MDCK Cells.

Mishel P, Bychkov D, Kallio-Kokko H, Valkonen M, Kantele A, Mattila P, Almusa H, Jalovaara P, Kainov D.

Genome Announc. 2014 Dec 24;2(6). pii: e01349-14. doi: 10.1128/genomeA.01349-14.

15.

Genetic Instability of Influenza pH1N1 Viruses.

Jalovaara P, Bychkov D, Ahtiainen L, Kallio-Kokko H, Valkonen M, Kantele A, Mattila P, Almusa H, Kallioniemi O, Kainov D.

Genome Announc. 2014 Oct 2;2(5). pii: e00841-14. doi: 10.1128/genomeA.00841-14.

16.

Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6.

Nukolova NV, Baklaushev VP, Abakumova TO, Mel'nikov PA, Abakumov MA, Yusubalieva GM, Bychkov DA, Kabanov AV, Chekhonin VP.

Bull Exp Biol Med. 2014 Aug;157(4):524-9. doi: 10.1007/s10517-014-2606-x. Epub 2014 Aug 12.

PMID:
25110098
17.

Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro.

Denisova OV, Söderholm S, Virtanen S, Von Schantz C, Bychkov D, Vashchinkina E, Desloovere J, Tynell J, Ikonen N, Theisen LL, Nyman TA, Matikainen S, Kallioniemi O, Julkunen I, Muller CP, Saelens X, Verkhusha VV, Kainov DE.

Antimicrob Agents Chemother. 2014 Jul;58(7):3689-96. doi: 10.1128/AAC.02798-13. Epub 2014 Apr 21.

Supplemental Content

Loading ...
Support Center